Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,662.3
-7.2 (-0.27%)

 

  • STI Straits Times Index
    2,662.3
    -7.2 (-0.27%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,581.2
    -2.3 (-0.15%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,129.2
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,403.4
    -
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,492.0
    53.4 (0.24%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,076.2
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 389.2M
  • Value: 138.2M
  • Rise: 112
  • Fall: 61
  • Unch: 635

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
AsiaMedic0.032+0.012
Singapore-eDev0.134+0.001
QT Vascular0.005-
Medtecs Intl0.860+0.040
Thomson Medical0.060+0.001
Healthway Med0.038+0.003
3Cnergy0.020+0.003
Clearbridge0.177+0.005
Biolidics0.355+0.045
Jiutian Chemical0.017-

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CANTEL MEDICAL CORP CANTEL MEDICAL CORP
Updated on 08 Jul 2020 (End of trading day)
Last (USD): 43.800 Change: -0.010 High: 44.550 Remarks: -
Change (%): -0.02 Low: 42.550
Open 43.720 Yesterday's Close 43.809999999999995
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 440,949 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 1.30452 Trailing EPS (USD) e 0.66693 NAV (USD) b 16.3321
PE a 33.576 Trailing PE f 65.674 Price / NAV b 2.6818
Dividend (USD) d 0.198182 Cash In Hand (USD) g 2.7462 Issued & Paid-up Shares c 42,154,300
Dividend Yield (%) d 0.452 Price / Cash In Hand g 15.949 Treasury Shares h 4,645,300
Market Cap (M) 1,846.358 Enterprise Value (M) 2,762.215
Piotroski F Score 4 Exchange Code CMD Par Value ( $ ) n.a.
52 Weeks Volatility (%) 95.04 Free Float (%) -
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 10 Jun 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 10 Jun 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CANTEL MEDICAL CORP NYSE 1,846.358 33.576 65.674 2.6818 0.452
Industry Medical Specialties NYSE 29,332.624 34.034 35.583 3.9905 0.753
Local Peer ABBOTT LABORATORIES NYSE 163,760.133 44.670 46.273 5.4193 1.421
Local Peer THERMO FISHER SCIENTIFIC INC NYSE 152,699.905 41.315 41.619 5.3468 0.198
Local Peer DANAHER CORP NYSE 130,651.796 52.496 47.735 4.4356 0.362
Local Peer MEDTRONIC PLC NYSE 122,876.493 25.658 25.658 2.4218 2.357
Local Peer BECTON DICKINSON & CO NYSE 71,643.648 66.214 78.729 3.4199 1.170
Local Peer STRYKER CORP NYSE 68,132.486 32.709 31.485 5.1950 1.174
Local Peer BOSTON SCIENTIFIC CORP NYSE 49,362.622 10.503 11.514 3.5760 -
Local Peer BAXTER INTERNATIONAL INC NYSE 42,833.814 42.791 41.953 5.5636 1.004
Local Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 42,960.931 32.891 32.891 3.0382 1.910
Local Peer EDWARDS LIFESCIENCES CORP NYSE 42,608.097 40.699 38.462 10.9221 -
Local Peer ALCON AG NYSE 28,105.572 - - 1.4660 -
Local Peer RESMED INC NYSE 27,880.417 68.910 54.386 12.3560 0.783
Other Local Peers ZIMMER BIOMET HOLDINGS INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), STERIS PLC (NYSE), WATERS CORP (NYSE), PERKINELMER INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), QIAGEN NV (NYSE), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), HAEMONETICS CORP (NYSE), GLOBUS MED INC (NYSE), NEVRO CORP (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), CONMED CORP (NYSE), GLAUKOS CORPORATION (NYSE), AVANOS MEDICAL INC (NYSE), VAPOTHERM INC (NYSE), CRYOLIFE INC (NYSE), INVACARE CORP (NYSE), RA MEDICAL SYSTEMS INC (NYSE)
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,095.000 48.644 48.399 7.8873 -
Global Peer DEXCOM INC NASDAQ 39,306.878 388.793 265.767 42.0619 -
Global Peer IDEXX LABORATORIES INC NASDAQ 28,647.901 66.978 65.576 266.0514 -
Global Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 22,466.161 69.189 169.624 10.6118 -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 21,636.956 48.867 11.454 7.5840 -
Global Peer HOLOGIC INC NASDAQ 14,679.011 - 23.822 7.0366 -
Global Peer INSULET CORPORATION NASDAQ 13,565.415 1,169.399 2,632.017 229.9275 -
Global Peer FISHER & PAYKEL HEALTHCARE CORP ASX 19,086.614 69.918 69.918 20.2351 0.925
Global Peer HARTA Bursa 55,631.059 127.951 127.952 21.8933 -
Global Peer TOPGLOV Bursa 55,174.144 151.300 84.992 16.3500 0.348
Other Global Peers Top Glove (SGX), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), WEIGAO GROUP (HKEx), DENTSPLY SIRONA INC (NASDAQ), QUIDEL CORP (NASDAQ), MICROPORT (HKEx), COCHLEAR LTD (ASX), BRUKER CORPORATION (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), NOVOCURE LTD (NASDAQ), KANGJI MEDICAL (HKEx), VENUS MEDTECH-B (HKEx), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), AK MEDICAL (HKEx), INOVIO PHARMACEUTICALS INC (NASDAQ), SUPERMX (Bursa), IRHYTHM TECHNOLOGIES INC (NASDAQ), PEIJIA-B (HKEx), NUVASIVE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), LIVANOVA PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), EBOS GROUP (ASX), INARI MEDICAL INC (NASDAQ), ATRICURE INC (NASDAQ), CAREDX INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), KDL MEDICAL (HKEx), SILK ROAD MEDICAL INC (NASDAQ), NANOSONICS LIMITED (ASX), BIOTELEMETRY INC (NASDAQ), LIFETECH SCI (HKEx), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), CIRC (HKEx), ZYNEX INC (NASDAQ), HESKA CORP (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), INOGEN INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), SURMODICS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), TRANSMEDICS GROUP INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), AXOGEN INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), YESTAR HEALTH (HKEx), CYTOSORBENTS CORP (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), PW MEDTECH (HKEx), CORMEDIX INC (NYSE American), MEDICAL DEVELOPMENT INTL (ASX), STEREOTAXIS INC (NYSE American), VIEWRAY INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), GOLDEN MEDITECH (HKEx), Medtecs Intl (SGX), PROFOUND MED CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ALPHA PRO TECH (NYSE American), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), UG Healthcare (SGX), MISONIX INC (NASDAQ), CUTERA INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), DERMTECH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), VINCENT MED (HKEx), SIENTRA INC (NASDAQ), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), SOLITON INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), MODERN DENTAL (HKEx), SOLENO THERAPEUTICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), FONAR CORP (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ROCKWELL MEDICAL INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), ELECTROMED INC (NYSE American), CELSION CORPORATION (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), CYCLOPHARM LIMITED (ASX), RESAPP HEALTH LIMITED (ASX), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), SOMNOMED LIMITED (ASX), NOVA EYE MEDICAL LIMITED (ASX), YUNNAN ENERGY (HKEx), MILESTONE SCIENTIFIC INC (NYSE American), DAXOR CORP (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), LKL (Bursa), Biolidics (SGX), CONFORMIS INC (NASDAQ), SDI LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), COMPUMEDICS (ASX), TITAN MEDICAL INC (NASDAQ), IMPEDIMED LIMITED (ASX), DIMERIX LTD (ASX), RESONANCE HEALTH LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), KELFRED (HKEx), RESPIRI LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), IMMUCELL CORP (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), ONCOCYTE CORP (NYSE American), STRATA SKIN SCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), NEURONETICS INC (NASDAQ), MICRO-X LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ELECTROCORE INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), IRIDEX CORP (NASDAQ), Yunnan Energy (SGX), OVENTUS MEDICAL LTD (ASX), LBT INNOVATIONS LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), NEUROTROPE INC (NASDAQ), METALICITY LIMITED (ASX), USCOM LTD (ASX), DARIOHEALTH CORP (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), CHF SOLUTIONS INC (NASDAQ), BIOLASE INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), LIFE HEALTHCARE (HKEx), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), AVINGER INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), AETHLON MEDICAL INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), DIGIRAD CORP (NASDAQ), OPTISCAN IMAGING (ASX), CYANOTECH CORP (NASDAQ), CARDIEX LTD (ASX), DYNATRONICS CORP (NASDAQ), Annica (SGX), ADHERIUM LIMITED (ASX), VIVEVE MEDICAL INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ENDOLOGIX INC (NASDAQ), NEUROMETRIX INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), HUAKANG BIOMED (HKEx), STHAI (SET), ANALYTICA (ASX), DORSAVI LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.620
-1.40 %
10 Days -+1.800
+4.29 %
20 Days -+0.090
+0.21 %
Medium Term Return 3 Months -+9.850
+29.01 %
6 Months 0.105-22.320
-33.60 %
1 Year 0.205-35.580
-44.56 %
Long Term Return 2 Years 0.390-49.780
-52.78 %
3 Years 0.545-31.820
-41.36 %
Annualised Return Annualised --
-16.30 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 20.810 - 93.870 Change From 1 Year Low +22.990 % Change From 1 Year Low (%) +110.48
Change From 1 Year High -50.070 % Change From 1 Year High (%) -53.34
2 Years Range 20.810 - 99.684 Change From 2 Years Low +22.990 % Change From 2 Years Low (%) +110.48
Change From 2 Years High -55.884 % Change From 2 Years High (%) -56.06
5 Years Range 20.810 - 130.920 Change From 5 Years Low +22.990 % Change From 5 Years Low (%) +110.48
Change From 5 Years High -87.120 % Change From 5 Years High (%) -66.54
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Cantel Medical Corp. engages in the development and manufacture of infection prevention products and services in the healthcare market. It operates through the following business segments: Medical, Life Sciences, Dental and Dialysis. The Medical segment designs, develops, manufactures, sells and installs a comprehensive offering of products and services comprising a complete circle of infection prevention solutions. The Life Sciences segment designs, develops, manufactures, sells and installs water purification systems for medical, pharmaceutical and other bacteria controlled applications. The Dental segment designs, manufactures, sells, supplies and distributes a broad selection of infection prevention healthcare products, the majority of which are single-use products used by dental practitioners. The Dialysis segment designs, develops, manufactures, sells and services reprocessing systems and sterilants for dialyzers as well as dialysate concentrates and supplies utilized for renal dialysis. Cantel Medical was founded on August 16, 1963 and is headquartered in Little Falls, NJ.

Historical Price Data

Date Open High Low Close Volume VWAP
07 Jul 2020 44.230 45.270 43.720 43.810 626,004 -
06 Jul 2020 44.670 45.400 44.000 45.070 681,801 -
02 Jul 2020 45.450 45.740 44.080 44.530 351,340 -
01 Jul 2020 44.110 45.200 43.580 44.420 306,329 -
30 Jun 2020 43.500 44.870 42.760 44.230 773,205 -
29 Jun 2020 41.000 44.140 39.720 43.940 511,650 -
26 Jun 2020 42.180 42.650 39.530 40.010 4,777,267 -
25 Jun 2020 41.980 43.080 41.645 42.420 651,073 -
24 Jun 2020 44.450 44.615 41.960 42.000 678,264 -
23 Jun 2020 45.340 46.130 44.800 45.410 512,857 -
22 Jun 2020 43.500 45.750 42.900 44.620 618,135 -
19 Jun 2020 42.240 44.540 42.240 43.610 883,433 -
18 Jun 2020 40.570 42.290 40.150 41.680 387,179 -
17 Jun 2020 42.810 42.950 40.960 41.100 355,885 -
16 Jun 2020 45.250 46.020 41.890 42.560 597,620 -
15 Jun 2020 39.730 44.360 39.400 42.850 489,557 -
12 Jun 2020 42.230 43.150 39.480 41.510 650,111 -
11 Jun 2020 41.520 42.130 39.640 39.940 678,282 -
10 Jun 2020 47.760 48.060 43.450 43.710 712,706 -
09 Jun 2020 50.220 50.980 47.730 47.980 762,137 -
08 Jun 2020 50.950 53.310 49.760 51.240 1,409,427 -
05 Jun 2020 49.800 54.090 49.720 50.190 954,163 -
Summary
Current 2 Weeks
(23 Jun 2020 to 07 Jul 2020)
45.340 46.130 39.530 43.810 9,869,790 -
Previous 2 Weeks
(09 Jun 2020 to 22 Jun 2020)
50.220 50.980 39.530 44.620 6,135,045 -
4 Weeks from
(11 May 2020 to 08 Jun 2020)
36.050 46.130 34.145 51.240 23,107,432 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.